Alex Denoon > Bristows LLP > London, England > Lawyer Profile

Bristows LLP
100 VICTORIA EMBANKMENT
LONDON
EC4Y 0DH
England

Living Wage

Work Department

Life Sciences Regulatory

Position

Alex is passionate about the Life Sciences sector and advises about regulatory issues all day every day.

Alex’s advice is informed by a BSc in Human Genetics and in-house experience including as GC of a biopharmaceutical company and brings 25 years’ experience advising clients in the sector.

In addition to a wide array of contentious (judicial review) matters, he enjoys working with clients to devise and implement regulatory strategies throughout the product life cycle of pharmaceuticals and medical devices.

Alex has advised a number of clients in relation to challenging issues including genomics, cell and gene therapies, 3D printing, healthcare Apps, companion diagnostics, borderline products and combination products.

Alex has been involved in the development of a number of regulatory frameworks and guidelines.

Legal 500 describes Alex as “a straight-talking, commercially astute technology specialist who is always willing to take a view” and who delivers “out-of-the-box solutions”.

Career

Qualified in Australia in 1995 at Freehills; partner since 2009.

Education

University of New South Wales (LLB and B.Sc. (Human Genetics))

Leisure

Family, wine and travel.

Lawyer Rankings

London > Industry focus > Life sciences and healthcare

(Leading individuals)

Alex DenoonBristows LLP

Bristows LLP houses a ‘truly exceptional‘ practice which assists clients with the full gamut of commercial, regulatory and IP-related issues. Liz Cohen co-leads the team with Richard Dickinson; Cohen has longstanding expertise in multi-jurisdictional litigation concerning patent revocations, and arbitrations, and Dickinson has in-depth knowledge of biochemistry, often assisting pharmaceutical companies with licensing and manufacturing agreements. Using her in-house experience in the medical device industry, Claire Smith has deep knowledge of licensing and commercial partnership agreements. Brian Cordery ‘goes above and beyond‘ when acting in contentious IP issues, including patent revocation and defence work, while Robert Burrows utilises his knowledge of molecular biology to advise clients on patent validity challenges. Matthew Warren is noted for his commercial expertise, often handling settlements and license agreements, and Marek Petecki regularly assists biopharma corporates and venture capital investors with transactional matters. Alex Denoon has ‘excellent regulatory knowledge‘, often advising disruptive technology clients on human tissue and genomics issues.